Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate a peer-based HIV prevention intervention that targets active injection drug users and their drug and sex partners.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Johns Hopkins Bloomberg School of Public Health
Collaborators
NCT07209917 · Cervical Cancer, Human Papillomavirus (HPV) Infection, and more
NCT06632444 · Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
NCT07388394 · Virus-HIV
NCT07392372 · HIV -1 Infection
NCT06853314 · HIV Infections, Alcohol Use Disorder, and more
The Lighthouse
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions